Skip to main content Accessibility help
×
×
Home

Oats and CVD risk markers: a systematic literature review

  • Frank Thies (a1), Lindsey F. Masson (a2) (a3), Paolo Boffetta (a4) (a5) and Penny Kris-Etherton (a6)
Abstract

High consumption of whole-grain food such as oats is associated with a reduced risk of CVD and type 2 diabetes. The present study aimed to systematically review the literature describing long-term intervention studies that investigated the effects of oats or oat bran on CVD risk factors. The literature search was conducted using Embase, Medline and the Cochrane library, which identified 654 potential articles. Seventy-six articles describing sixty-nine studies met the inclusion criteria. Most studies lacked statistical power to detect a significant effect of oats on any of the risk factors considered: 59 % of studies had less than thirty subjects in the oat intervention group. Out of sixty-four studies that assessed systemic lipid markers, thirty-seven (58 %) and thirty-four (49 %) showed a significant reduction in total cholesterol (2–19 % reduction) and LDL-cholesterol (4–23 % reduction) respectively, mostly in hypercholesterolaemic subjects. Few studies (three and five, respectively) described significant effects on HDL-cholesterol and TAG concentrations. Only three out of twenty-five studies found a reduction in blood pressure after oat consumption. None of the few studies that measured markers of insulin sensitivity and inflammation found any effect after long-term oat consumption. Long-term dietary intake of oats or oat bran has a beneficial effect on blood cholesterol. However, there is no evidence that it favourably modulates insulin sensitivity. It is still unclear whether increased oat consumption significantly affects other risk markers for CVD risk, and comprehensive, adequately powered and controlled intervention trials are required to address this question.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Oats and CVD risk markers: a systematic literature review
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Oats and CVD risk markers: a systematic literature review
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Oats and CVD risk markers: a systematic literature review
      Available formats
      ×
Copyright
Corresponding author
* Corresponding author: F. Thies, fax +44 1224 554761, email f.thies@abdn.ac.uk
References
Hide All
1 Jacobs, DRJ, Meyer, KA, Kushi, LH, et al. (1998) Whole-grain intake may reduce the risk of ischemic heart disease death in postmenopausal women: the Iowa Women's Health Study. Am J Clin Nutr 68, 248257.
2 Liu, S, Stampfer, MJ, Hu, FB, et al. (1999) Whole-grain consumption and risk of coronary heart disease: results from the Nurses’ Health Study. Am J Clin Nutr 70, 412419.
3 Whelton, SP, Hyre, AD, Pedersen, B, et al. (2005) Effect of dietary fiber intake on blood pressure: a meta-analysis of randomized, controlled clinical trials. J Hypertens 23, 475481.
4 Salmerón, J, Manson, JE, Stampfer, MJ, et al. (1997) Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA 277, 472477.
5 Meyer, KA, Kushi, LH, Jacobs, DRJ, et al. (2000) Carbohydrates, dietary fiber, and incident type 2 diabetes in older women. Am J Clin Nutr 71, 921930.
6 Anderson, JW & Hanna, TJ (1999) Impact of nondigestible carbohydrates on serum lipoproteins and risk for cardiovascular disease. J Nutr 129, Suppl. 7, 1457S1466S.
7 Tighe, P, Duthie, G, Vaughan, N, et al. (2010) Effect of increased consumption of whole-grain foods on blood pressure and other cardiovascular risk markers in healthy middle-aged persons: a randomized controlled trial. Am J Clin Nutr 92, 733740.
8 Anderson, JW (2003) Whole grains protect against atherosclerotic cardiovascular disease. Proc Nutr Soc 62, 135142.
9 Marckmann, P, Sandström, B & Jespersen, J (1994) Low-fat, high-fiber diet favorably affects several independent risk markers of ischemic heart disease: observations on blood lipids, coagulation, and fibrinolysis from a trial of middle-aged Danes. Am J Clin Nutr 59, 935939.
10 King, DE, Egan, BM & Geesey, ME (2003) Relation of dietary fat and fiber to elevation of C-reactive protein. Am J Cardiol 92, 13351339.
11 Brownlee, IA, Moore, C, Chatfield, M, et al. (2010) Markers of cardiovascular risk are not changed by increased whole-grain intake: the WHOLEheart study, a randomised, controlled dietary intervention. Br J Nutr 104, 125134.
12 Anderson, JW (1995) Cholesterol-lowering effects of soluble fiber in humans. In Dietary Fiber in Health and Disease, pp. 126145 [Kritchevsky, D and Bonfield, C, editors]. St Paul, MN: Eagan Press.
13 Tosh, SM (2013) Review of human studies investigating the post-prandial blood-glucose lowering ability of oat and barley food products. Eur J Clin Nutr 67, 310317.
14 Halpern, SH and Douglas, MJ (editors) Appendix: Jadad scale for reporting randomized controlled trials. In (2005, 2007) Evidence-Based Obstetric Anesthesia, pp. 237238. Blackwell Publishing Ltd., Oxford, UK.
15 Abrahamsson, L, Goranzon, H, Karlstrom, B, et al. (1994) Metabolic effects of oat bran and wheat bran in healthy women. Scand J Nutr Naringsforsk 38, 510.
16 Anderson, JW, Story, L, Sieling, B, et al. (1984) Hypocholesterolemic effects of oat-bran or bean intake for hypercholesterolemic men. Am J Clin Nutr 40, 11461155.
17 Anderson, JW, Spencer, DB, Hamilton, CC, et al. (1990) Oat-bran cereal lowers serum total and LDL cholesterol in hypercholesterolemic men. Am J Clin Nutr 52, 495499.
18 Anderson, JW, Gilinsky, NH, Deakins, DA, et al. (1991) Lipid responses of hypercholesterolemic men to oat-bran and wheat-bran intake. Am J Clin Nutr 54, 678683.
19 Bridges, SR, Anderson, JW, Deakins, DA, et al. (1992) Oat bran increases serum acetate of hypercholesterolemic men. Am J Clin Nutr 56, 455459.
20 Bremer, JM, Scott, RS & Lintott, CJ (1991) Oat bran and cholesterol reduction: evidence against specific effect. Aust N Z J Med 21, 422426.
21 Davidson, MH, Dugan, LD, Burns, JH, et al. (1991) The hypocholesterolemic effects of beta-glucan in oatmeal and oat bran. A dose-controlled study. JAMA 265, 18331839.
22 Demark-Wahnefried, W, Bowering, J & Cohen, PS (1990) Reduced serum cholesterol with dietary change using fat-modified and oat bran supplemented diets. J Am Diet Assoc 90, 223229.
23 Dubois, C, Armand, M, Senft, M, et al. (1995) Chronic oat bran intake alters postprandial lipemia and lipoproteins in healthy adults. Am J Clin Nutr 61, 325333.
24 Hegsted, M, Windhauser, MM, Morris, SK, et al. (1993) Stabilized rice bran and oat bran lower cholesterol in humans. Nutr Res 13, 387398.
25 Jenkins, DJ, Nguyen, TH, Kendall, CW, et al. (2008) The effect of strawberries in a cholesterol-lowering dietary portfolio. Metabolism 57, 16361644.
26 Judd, PA & Truswell, S (1981) The effect of rolled oats on blood lipids and fecal steroid excretion in man. Am J Clin Nutr 34, 20612067.
27 Kahn, RF, Davidson, KW, Garner, J, et al. (1990) Oat bran supplementation for elevated serum cholesterol. Fam Pract Res J 10, 3746.
28 Kelley, MJ, Hoover-Plow, J, Nichols-Bernhard, JF, et al. (1994) Oat bran lowers total and low-density lipoprotein cholesterol but not lipoprotein(a) in exercising adults with borderline hypercholesterolemia. J Am Diet Assoc 94, 14191421.
29 Kerckhoffs, DA, Hornstra, G & Mensink, RP (2003) Cholesterol-lowering effect of beta-glucan from oat bran in mildly hypercholesterolemic subjects may decrease when beta-glucan is incorporated into bread and cookies. Am J Clin Nutr 78, 221227.
30 Kirby, RW, Anderson, JW, Sieling, B, et al. (1981) Oat-bran intake selectively lowers serum low-density lipoprotein cholesterol concentrations of hypercholesterolemic men. Am J Clin Nutr 34, 824829.
31 Kretsch, MJ, Crawford, L & Calloway, DH (1979) Some aspects of bile acid and urobilinogen excretion and fecal eliminiation in men given a rural Guatemalan diet and egg formulas with and without added oat bran. Am J Clin Nutr 32, 14921496.
32 Calloway, DH & Kretsch, MJ (1978) Protein and energy utilization in men given a rural Guatemalan diet and egg formulas with and without added oat bran. Am J Clin Nutr 31, 11181126.
33 Kristensen, M & Bugel, S (2011) A diet rich in oat bran improves blood lipids and hemostatic factors, and reduces apparent energy digestibility in young healthy volunteers. Eur J Clin Nutr 65, 10531058.
34 Maki, KC, Davidson, MH, Witchger, MS, et al. (2007) Effects of high-fiber oat and wheat cereals on postprandial glucose and lipid responses in healthy men. Int J Vit Nutr Res 77, 347356.
35 Maki, KC, Galant, R, Samuel, P, et al. (2007) Effects of consuming foods containing oat beta-glucan on blood pressure, carbohydrate metabolism and biomarkers of oxidative stress in men and women with elevated blood pressure. Eur J Clin Nutr 61, 786795.
36 Marlett, JA, Hosig, KB, Vollendorf, NW, et al. (1994) Mechanism of serum cholesterol reduction by oat bran. Hepatology 20, 14501457.
37 Noakes, M, Clifton, PM, Nestel, PJ, et al. (1996) Effect of high-amylose starch and oat bran on metabolic variables and bowel function in subjects with hypertriglyceridemia. Am J Clin Nutr 64, 944951.
38 Onning, G, Akesson, B, Oste, R, et al. (1998) Effects of consumption of oat milk, soya milk, or cow's milk on plasma lipids and antioxidative capacity in healthy subjects. Ann Nutr Metab 42, 211220.
39 Robitaille, J, Fontaine-Bisson, B, Couture, P, et al. (2005) Effect of an oat bran-rich supplement on the metabolic profile of overweight premenopausal women. Ann Nutr Metab 49, 141148.
40 Romero, AL, Romero, JE, Galaviz, S, et al. (1998) Cookies enriched with psyllium or oat bran lower plasma LDL cholesterol in normal and hypercholesterolemic men from Northern Mexico. J Am Coll Nutr 17, 601608.
41 Saltzman, E, Das, SK, Lichtenstein, AH, et al. (2001) An oat-containing hypocaloric diet reduces systolic blood pressure and improves lipid profile beyond effects of weight loss in men and women. J Nutr 131, 14651470.
42 Spiller, GA, Farquhar, JW, Gates, JE, et al. (1991) Guar gum and plasma cholesterol. Effect of guar gum and an oat fiber source on plasma lipoproteins and cholesterol in hypercholesterolemic adults. Arterioscler Thromb 11, 12041208.
43 Stewart, FM, Neutze, JM & Newsome-White, R (1992) The addition of oatbran to a low fat diet has no effect on lipid values in hypercholesterolaemic subjects. N Z Med J 105, 398400.
44 Sturtzel, B, Dietrich, A, Wagner, KH, et al. (2010) The status of vitamins B6, B12, folate, and of homocysteine in geriatric home residents receiving laxatives or dietary fiber. J Nutr Health Aging 14, 219223.
45 Turnbull, WH & Leeds, AR (1987) Reduction of total and LDL-cholesterol in plasma by rolled oats. J Clin Nutr Gastroenterol 2, 177181.
46 Whyte, JL, McArthur, R, Topping, D, et al. (1992) Oat bran lowers plasma cholesterol levels in mildly hypercholesterolemic men. J Am Diet Assoc 92, 446449.
47 Zhang, JX, Hallmans, G, Andersson, H, et al. (1992) Effect of oat bran on plasma cholesterol and bile acid excretion in nine subjects with ileostomies. Am J Clin Nutr 56, 99105.
48 Beck, EJ, Tapsell, LC, Batterham, MJ, et al. (2010) Oat beta-glucan supplementation does not enhance the effectiveness of an energy-restricted diet in overweight women. Br J Nutr 103, 12121222.
49 Davy, BM, Davy, KP, Ho, RC, et al. (2002) High-fiber oat cereal compared with wheat cereal consumption favorably alters LDL-cholesterol subclass and particle numbers in middle-aged and older men. Am J Clin Nutr 76, 351358.
50 Davy, BM, Melby, CL, Beske, SD, et al. (2002) Oat consumption does not affect resting casual and ambulatory 24-h arterial blood pressure in men with high-normal blood pressure to stage I hypertension. J Nutr 132, 394398.
51 Conceicao de Oliveira, M, Sichieri, R & Sanchez Moura, A (2003) Weight loss associated with a daily intake of three apples or three pears among overweight women. Nutrition 19, 253256.
52 Frank, J, Sundberg, B, Kamal-Eldin, A, et al. (2004) Yeast-leavened oat breads with high or low molecular weight beta-glucan do not differ in their effects on blood concentrations of lipids, insulin, or glucose in humans. J Nutr 134, 13841388.
53 Gerhardt, AL & Gallo, NB (1998) Full-fat rice bran and oat bran similarly reduce hypercholesterolemia in humans. J Nutr 128, 865869.
54 Gold, KV & Davidson, DM (1988) Oat bran as a cholesterol-reducing dietary adjunct in a young, healthy population. West J Med 148, 299302.
55 Keenan, JM, Pins, JJ, Frazel, C, et al. (2002) Oat ingestion reduces systolic and diastolic blood pressure in patients with mild or borderline hypertension: a pilot trial. J Fam Pract 51, 369.
56 Kestin, M, Moss, R, Clifton, PM, et al. (1990) Comparative effects of three cereal brans on plasma lipids, blood pressure, and glucose metabolism in mildly hypercholesterolemic men. Am J Clin Nutr 52, 661666.
57 Swain, JF, Rouse, IL, Curley, CB, et al. (1990) Comparison of the effects of oat bran and low-fiber wheat on serum lipoprotein levels and blood pressure. N Engl J Med 322, 147152.
58 Uusitupa, MI, Miettinen, TA, Sarkkinen, ES, et al. (1997) Lathosterol and other non-cholesterol sterols during treatment of hypercholesterolaemia with beta-glucan-rich oat bran. Eur J Clin Nutr 51, 607611.
59 Uusitupa, MI, Ruuskanen, E, Makinen, E, et al. (1992) A controlled study on the effect of beta-glucan-rich oat bran on serum lipids in hypercholesterolemic subjects: relation to apolipoprotein E phenotype. J Am Coll Nutr 11, 651659.
60 Kemppainen, T, Heikkinen, M, Ristikankare, M, et al. (2009) Effect of unkilned and large amounts of oats on nutritional state of celiac patients in remission. e-SPEN 4, e30e34.
61 Leadbetter, J, Ball, MJ & Mann, JI (1991) Effects of increasing quantities of oat bran in hypercholesterolemic people. Am J Clin Nutr 54, 841845.
62 Mackay, S & Ball, MJ (1992) Do beans and oat bran add to the effectiveness of a low-fat diet? Eur J Clin Nutr 46, 641648.
63 Poulter, N, Chang, CL, Cuff, A, et al. (1994) Lipid profiles after the daily consumption of an oat-based cereal: a controlled crossover trial. Am J Clin Nutr 59, 6669.
64 Van Horn, L, Moag-Stahlberg, A, Liu, KA, et al. (1991) Effects on serum lipids of adding instant oats to usual American diets. Am J Public Health 81, 183188.
65 Winblad, I, Joensuu, T & Korpela, H (1995) Effect of oat bran supplemented diet on hypercholesterolaemia. Scand J Prim Health Care 13, 118121.
66 Charlton, KE, Tapsell, LC, Batterham, MJ, et al. (2012) Effect of 6 weeks’ consumption of β-glucan-rich oat products on cholesterol levels in mildly hypercholesterolaemic overweight adults. Br J Nutr 107, 10371047.
67 He, J, Streiffer, RH, Muntner, P, et al. (2004) Effect of dietary fiber intake on blood pressure: a randomized, double-blind, placebo-controlled trial. J Hypertens 22, 7380.
68 Kashtan, H, Stern, HS, Jenkins, DJ, et al. (1992) Wheat-bran and oat-bran supplements’ effects on blood lipids and lipoproteins. Am J Clin Nutr 55, 976980.
69 Hegele, RA, Zahariadis, G, Jenkins, AL, et al. (1993) Genetic variation associated with differences in the response of plasma apolipoprotein B levels to dietary fibre. Clin Sci 85, 269275.
70 Katz, DL, Nawaz, H, Boukhalil, J, et al. (2001) Effects of oat and wheat cereals on endothelial response. Prev Med 33, 476484.
71 Katz, DL, Evans, MA, Chan, W, et al. (2004) Oats, antioxidants and endothelial function in overweight, dyslipidemic adults. J Am Coll Nutr 23, 397403.
72 Katz, DL, Evans, MA, Nawaz, H, et al. (2005) Egg consumption and endothelial function: a randomized controlled crossover trial. Int J Cardiol 99, 6570.
73 Lepre, F & Crane, S (1992) Effect of oatbran on mild hyperlipidaemia. Med J Aust 157, 305308.
74 Onning, G, Wallmark, A, Persson, M, et al. (1999) Consumption of oat milk for 5 weeks lowers serum cholesterol and LDL cholesterol in free-living men with moderate hypercholesterolemia. Ann Nutr Metab 43, 301309.
75 Pins, JJ, Geleva, D, Keenan, JM, et al. (2002) Do whole-grain oat cereals reduce the need for antihypertensive medications and improve blood pressure control? J Fam Pract 51, 353359.
76 Theuwissen, E & Mensink, RP (2007) Simultaneous intake of beta-glucan and plant stanol esters affects lipid metabolism in slightly hypercholesterolemic subjects. J Nutr 137, 583588.
77 Theuwissen, E, Plat, J & Mensink, RP (2009) Consumption of oat beta-glucan with or without plant stanols did not influence inflammatory markers in hypercholesterolemic subjects. Mol Nutr Food Res 53, 370376.
78 Van Horn, L, Liu, K, Gerber, J, et al. (2001) Oats and soy in lipid-lowering diets for women with hypercholesterolemia: is there synergy? J Am Diet Assoc 101, 13191325.
79 Berg, A, Konig, D, Deibert, P, et al. (2003) Effect of an oat bran enriched diet on the atherogenic lipid profile in patients with an increased coronary heart disease risk. A controlled randomized lifestyle intervention study. Ann Nutr Metab 47, 306311.
80 Karmally, W, Montez, MG, Palmas, W, et al. (2005) Cholesterol-lowering benefits of oat-containing cereal in Hispanic Americans. J Am Diet Assoc 105, 967970.
81 Keenan, JM, Wenz, JB, Ripsin, CM, et al. (1992) A clinical trial of oat bran and niacin in the treatment of hyperlipidemia. J Fam Pract 34, 313319.
82 Maki, KC, Beiseigel, JM, Jonnalagadda, SS, et al. (2010) Whole-grain ready-to-eat oat cereal, as part of a dietary program for weight loss, reduces low-density lipoprotein cholesterol in adults with overweight and obesity more than a dietary program including low-fiber control foods. J Am Diet Assoc 110, 205214.
83 Van Horn, L, Emidy, LA, Liu, KA, et al. (1988) Serum lipid response to a fat-modified, oatmeal-enhanced diet. Prev Med 17, 377386.
84 Zhang, J, Li, L, Song, P, et al. (2012) Randomized controlled trial of oatmeal consumption versus noodle consumption on blood lipids of urban Chinese adults with hypercholesterolemia. Nutr J 11, 54.
85 Johnston, l, Reynolds, HR, Patz, M, et al. (1998) Cholesterol-lowering benefits of a whole grain oat ready-to-eat cereal. Nutr Clin Care 1, 612.
86 Keenan, JM, Wenz, JB, Myers, S, et al. (1991) Randomized, controlled, crossover trial of oat bran in hypercholesterolemic subjects. J Fam Pract 33, 600608.
87 Van Horn, LV, Liu, K, Parker, D, et al. (1986) Serum lipid response to oat product intake with a fat-modified diet. J Am Diet Assoc 86, 759764.
88 Wolever, TM, Tosh, SM, Gibbs, AL, et al. (2010) Physicochemical properties of oat β-glucan influence its ability to reduce serum LDL cholesterol in humans: a randomized clinical trial. Am J Clin Nutr 92, 723732.
89 Wolever, TM, Gibbs, AL, Brand-Miller, J, et al. (2011) Bioactive oat β-glucan reduces LDL cholesterol in Caucasians and non-Caucasians. Nutr J 10, 130.
90 Ripsin, CM, Keenan, JM, Jacobs, DRJ, et al. (1992) Oat products and lipid lowering. A meta-analysis. JAMA 267, 33173325.
91 National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106, 31433421.
92 Superko, HR & Gadesam, RR (2008) Is it LDL particle size or number that correlates with risk for cardiovascular disease? Curr Atheroscler Rep 10, 377385.
93 Barr, EL, Zimmet, PZ, Welborn, TA, et al. (2007) Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation 116, 151157.
94 Pearson, TA, Mensah, GA, Alexander, RW, et al. (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107, 499511.
95 Ajani, UA, Ford, ES & Mokdad, AH (2004) Dietary fiber and C-reactive protein: findings from national health and nutrition examination survey data. J Nutr 134, 11811185.
96 Ma, Y, Griffith, JA, Chasan-Taber, L, et al. (2006) Association between dietary fiber and serum C-reactive protein. Am J Clin Nutr 83, 760766.
97 Selhub, J (2008) Public health significance of elevated homocysteine. Food Nutr Bull 29, Suppl. 2, S116S125.
98 Raiko, JR, Oikonen, M, Wendelin-Saarenhovi, M, et al. (2012) Plasminogen activator inhibitor-1 associates with cardiovascular risk factors in healthy young adults in the Cardiovascular Risk in Young Finns Study. Atherosclerosis 224, 208212.
99 Noto, D, Barbagallo, CM, Cefalu’, AB, et al. (2002) Factor VII activity is an independent predictor of cardiovascular mortality in elderly women of a Sicilian population: results of an 11-year follow-up. Thromb Haemost 87, 206210.
100 European Food Safety Authority (2011) Scientific Opinion on the substantiation of health claims related to beta-glucans from oats and barley and maintenance of normal blood LDL-cholesterol concentrations (ID 1236, 1299), increase in satiety leading to a reduction in energy intake (ID 851, 852), reduction of post-prandial glycaemic responses (ID 821, 824), and “digestive function” (ID 850) pursuant to Article 13(1) of Regulation (EC) No. 1924/2006. EFSA J 9, 22072228.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

British Journal of Nutrition
  • ISSN: 0007-1145
  • EISSN: 1475-2662
  • URL: /core/journals/british-journal-of-nutrition
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords

Type Description Title
PDF
Supplementary materials

Thies Supplementary Material
Thies Supplementary Material

 PDF (155 KB)
155 KB

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed